SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 4.646
EU - Europa 3.169
AS - Asia 995
SA - Sud America 31
AF - Africa 23
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.884
Nazione #
US - Stati Uniti d'America 4.594
GB - Regno Unito 951
IT - Italia 926
SE - Svezia 424
CN - Cina 287
UA - Ucraina 221
DE - Germania 218
TR - Turchia 203
HK - Hong Kong 172
SG - Singapore 137
FI - Finlandia 109
FR - Francia 102
BG - Bulgaria 70
VN - Vietnam 45
IN - India 41
RU - Federazione Russa 40
CA - Canada 22
ID - Indonesia 22
MY - Malesia 21
BZ - Belize 19
RO - Romania 17
SA - Arabia Saudita 17
BE - Belgio 15
BR - Brasile 15
IR - Iran 15
CZ - Repubblica Ceca 14
IE - Irlanda 14
AU - Australia 12
NL - Olanda 10
CH - Svizzera 8
ET - Etiopia 8
PK - Pakistan 8
ES - Italia 7
EU - Europa 7
CO - Colombia 6
JP - Giappone 5
LT - Lituania 5
MX - Messico 5
PL - Polonia 5
CL - Cile 4
EE - Estonia 4
KR - Corea 4
TW - Taiwan 4
ZA - Sudafrica 4
EG - Egitto 3
GE - Georgia 3
KE - Kenya 3
TH - Thailandia 3
AN - Antille olandesi 2
AR - Argentina 2
BD - Bangladesh 2
DZ - Algeria 2
IQ - Iraq 2
LK - Sri Lanka 2
MK - Macedonia 2
PH - Filippine 2
PR - Porto Rico 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
CR - Costa Rica 1
EC - Ecuador 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RW - Ruanda 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 8.884
Città #
Southend 778
Fairfield 491
Chandler 455
Jacksonville 432
Woodbridge 320
Dearborn 318
Ashburn 295
Houston 238
Wilmington 221
Nyköping 212
Ann Arbor 203
Cambridge 192
Hong Kong 161
Seattle 157
Izmir 112
Beijing 101
Singapore 89
Princeton 86
San Diego 73
Eugene 71
Sofia 70
Des Moines 63
Milan 54
Rome 48
Dong Ket 44
Helsinki 41
Falls Church 39
Bremen 31
San Jose 31
New York 28
Jakarta 22
Redwood City 21
Belize City 19
Norwalk 17
Shanghai 17
London 16
Brussels 15
Modena 15
Naples 15
Brno 13
Buraidah 13
Palermo 13
Saint Petersburg 13
San Mateo 13
Verona 13
Saint Louis 12
Boardman 11
Nanjing 11
Ottawa 11
Kunming 10
Los Angeles 10
Philadelphia 10
Dublin 9
Florence 9
Torino 9
Auburn Hills 8
Axum 8
Bologna 8
Dallas 8
Munich 8
Bari 7
Hefei 7
Toronto 7
Cagliari 6
Leawood 6
Perugia 6
Turin 6
Albuquerque 5
Boulder 5
Catania 5
Chicago 5
Chiswick 5
Columbus 5
Fuzhou 5
Guangzhou 5
Indiana 5
Jinan 5
Las Vegas 5
Livorno 5
Mountain View 5
Nanchang 5
Napoli 5
Padova 5
Pune 5
Venice 5
Washington 5
Atlanta 4
Austin 4
Gurupi 4
Imola 4
Islamabad 4
L'aquila 4
Monmouth Junction 4
Parma 4
Phoenix 4
Reggio Calabria 4
Sant'Anastasia 4
Vercelli 4
Wuhan 4
Xian 4
Totale 6.027
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 610
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 370
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 336
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 217
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 212
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 201
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 198
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 193
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 176
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 176
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 170
Hodgkin's disease prognosis: a directly predictive equation 158
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 152
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 150
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 149
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 149
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 148
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 144
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 137
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 136
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 132
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 132
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 131
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 130
Trapianto di midollo osseo nelle aplasie midollari. 130
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 128
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 128
Detection of bone marrow involvement in patients with cancer 125
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 124
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 121
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 120
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 118
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 115
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 114
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 110
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 110
Studio clinico immunologico di sei casi di morbo di Behcet 110
Alimentazione e tumori III. Gli oligoelementi 108
Alimentazione e tumori II. Le vitamine 106
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 106
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 105
Istiocitosi maligna 105
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 105
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 104
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 103
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 103
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 102
Usefulness of breast MRI in a patient with genetic risk 102
Hereditary risk of breast cancer: not only brca 100
La chemioprevenzione del carcinoma mammario 100
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 99
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 96
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 96
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 96
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 95
Gli interferoni in terapia antineoplastica 93
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 93
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 93
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 91
La strategia terapeutica del GISL nei linfomi non-Hodgkin 91
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 89
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 86
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 84
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 84
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 80
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 78
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 71
Totale 9.124
Categoria #
all - tutte 31.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.561 0 0 0 165 195 253 375 153 139 59 120 102
2020/20211.296 124 34 190 74 116 78 115 155 78 127 80 125
2021/20221.294 28 159 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/2025241 117 39 50 35 0 0 0 0 0 0 0 0
Totale 9.124